Hearing Screening Test Results of Newborns Conceived by Intracytoplasmic Sperm Injection: A Retrospective Study of Tertiary Referral Center


Yasemin Sert U., ÇELİK H., Canpolat F. E., Sımsek G. K., Engin Ustun Y.

Fetal and Pediatric Pathology, vol.39, no.4, pp.288-296, 2020 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 39 Issue: 4
  • Publication Date: 2020
  • Doi Number: 10.1080/15513815.2019.1651804
  • Journal Name: Fetal and Pediatric Pathology
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, EMBASE, MEDLINE
  • Page Numbers: pp.288-296
  • Keywords: Asssisted Reproductive Technologies, Hearing screening, ABR, TEOAE, IN-VITRO FERTILIZATION, OTOACOUSTIC EMISSIONS, FOLLOW-UP, REPRODUCTIVE TECHNOLOGIES, CHILDREN, INFANTS, RISK, IDENTIFICATION, INTERVENTION, IMPAIRMENT
  • Lokman Hekim University Affiliated: No

Abstract

© 2019 Taylor & Francis Group, LLC.Objective: Assisted reproductive technologies (ART), especially intracytoplasmic sperm injection (ICSI), is associated with birth defects. However, there are few reports on hearing screening tests of these babies. We aimed to determine the association between ART and hearing loss in newborns. Materials and methods: This retrospective study examined 246 ICSI newborns between 2013 and 2015. All the patients conceived by ICSI. We examined the hearing screening results of the babies. Results: A total of 25 newborns did not pass the first screening test, including 17 by transient evoked otoacoustic emission (TEOAE) and 8 by auditory brainstem response (ABR). Ten babies did not pass the advanced examination. Total hearing loss affected 4% of ART babies. Conclusion: Hearing screening tests exposed deficient results in 4% of ICSI babies, which is ten times more frequent than spontaneously conceived newborns.